Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1798-1807
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1798
Table 1 Patient demographics and current colonoscopy findings
n = 1051 | Previous colonoscopy = Yes, n = 319 (30.4%) | Previous colonoscopy = No/unknown, n = 732 (69.6%) | P value |
Sex | |||
Male | 174 (54.5%) | 389 (53.1%) | 0.68 |
Age | |||
50-64 | 151 (47.3%) | 438 (59.8%) | < 0.001 |
65 + | 168 (52.7%) | 294 (40.2%) | |
Median age | 65 (range 50-75) | 62 (range 50-75) | < 0.001 |
Family history of CRC | |||
Yes | 52 (16.3%) | 56 (7.7%) | < 0.001 |
Symptomatic | |||
Any symptoms | 149 (46.7%) | 258 (35.2%) | < 0.001 |
Rectal bleeding | 66 (20.7%) | 112 (15.3%) | 0.03 |
Change in bowel pattern | 65 (20.4%) | 116 (15.8%) | 0.09 |
Abdominal pain | 35 (11%) | 46 (6.3%) | 0.014 |
Weight loss | 11 (3.4%) | 34 (4.6%) | 0.28 |
Anemia | 19 (6.0%) | 40 (5.5%) | 0.75 |
Current colonoscopy bowel preparation | |||
Good/excellent | 204 (63.9%) | 532 (72.7%) | 0.014 |
Poor | 23 (7.2%) | 46 (6.3%) | |
Complete colonoscopy | 311 (97.5%) | 715 (97.7%) | 0.42 |
CRC detected | 4 (1.3%) | 38 (5.2%) | 0.003 |
A-SSL detected | 146 (45.8%) | 367 (50.1%) | 0.19 |
AA-SSL detected | 57 (17.8%) | 200 (27.3%) | 0.002 |
Advanced neoplasia | 60 (18.8%) | 221 (30.2%) | < 0.001 |
Table 2 Time of previous colonoscopy in relation to current procedure
Time since previous colonoscopy; n = 319 | Frequency (%) |
< 1 yr | 2 (0.6) |
1-2 yr | 11 (3.4) |
2-3 yr | 18 (5.6) |
3-4 yr | 37 (11.6) |
4-5 yr | 37 (11.6) |
> 5 yr | 204 (63.9) |
Timing unknown | 10 (3.1) |
Table 3 Patients with colorectal cancer - previous and current colonoscopy findings
Patient | Gender | Age at current colonoscopy | Family history | Symptoms | Year of previous colonoscopy | Year of current colonoscopy | Quality of bowel preparation of previous colonoscopy | Quality of bowel preparation of current colonoscopy | Result of previous colonoscopy | Site of CRC | AJCC stage of CRC |
1 | Male | 71 | Nil | Nil | Oct 2012 | May 2017 | Good | Fair | Normal | Sigmoid colon | 1 |
2 | Male | 59 | Nil | Abdominal pain | 2010 | 2017 | Good | Good | Normal | Hepatic flexure | 3B |
3 | Female | 72 | Nil | Nil | > 10 yr | 2016 | Unknown | Good | Unknown | Rectum | 1 |
4 | Female | 72 | Nil | Nil | > 10 yr | 2019 | Unknown | Good | Unknown | Cecum | 1 |
Table 4 Diagnosis of advanced adenoma/sessile serrated lesion, advanced neoplasia and colorectal cancer as per time since previous colonoscopy
Total = 1051 | Had a previous colonoscopy, n = 319 | Never had or uncertain of previous colonoscopy, n = 732 | ||||
0-4 yr, (n = 68) | 4-5 yr (n = 37) | > 5 yr (n = 204) | Unsure when (n = 10) | Never (n = 685) | Unsure (n = 47) | |
AA-SSL | 7 (10.3%) | 7 (18.9%) | 41 (20.1%) | 1 (10%) | 181 (26.4%) | 19 (40.4%) |
Advanced neoplasia | 7 (10.3%) | 8 (21.6%) | 44 (21.6%) | 1 (10%) | 202 (29.5%) | 19 (40.4%) |
CRC | 0 | 1 (2.7%) | 3 (1.5%) | 0 | 37 (5.4%) | 1 (2.1%) |
Table 5 Patients with advanced adenoma/sessile serrated lesion - previous and current colonoscopy findings
Patient | Gender | Age at current colonoscopy | Family history | Symptoms | Year of previous colonoscopy | Year of current colonoscopy | Quality of bowel preparation of previous colonoscopy | Quality of bowel preparation of current colonoscopy | Result of previous colonoscopy | Most advanced histology on current colonoscopy | Size of largest polyp (mm) |
1 | Male | 74 | Nil | Altered bowel pattern, abdominal pain | 2012 | 2015 | Unknown | Fair | Melanosis coli | Serrated adenoma | 13 |
2 | Female | 70 | Nil | Abdominal pain | 2015 | 2017 | Good | Good | Angioectasia | Tubular adenoma with LGD | 10 |
3 | Male | 74 | Nil | Nil | 2016 | 2019 | Fair | Excellent | Tubular adenomas × 4 | Tubulovillous adenoma with LGD | 20 |
4 | Male | 75 | Nil | Nil | 2016 | 2017 | Poor | Fair | Tubular adenoma × 1 | Tubulovillous adenoma with LGD | 15 |
5 | Male | 71 | Nil | Nil | 2015 | 2018 | Poor | Good | Normal | Tubular adenoma with LGD | 10 |
6 | Male | 70 | Nil | Nil | 2012 | 2015 | Unknown | Good | Unknown | Tubular adenoma with LGD | 10 |
7 | Male | 58 | Nil | Nil | 2015 | 2018 | Unknown | Fair | Unknown | Tubular adenoma with LGD | 10 |
Table 6 Univariate and multivariate analyses of predictors of advanced neoplasia in the entire cohort
Variable | Univariate analysis | Multivariate analysis | ||||
OR | 95%CI | P value | OR | 95%CI | P value | |
Gender: Male | 1.78 | 1.34-2.36 | < 0.001 | 1.80 | 1.35-2.40 | < 0.001 |
Increasing age (continuous variable) | 1.04 | 1.02-1.06 | < 0.001 | 1.04 | 1.02-1.06 | < 0.001 |
Family history of CRC | 1.07 | 0.68-1.68 | 0.77 | 2.07 | 1.49-2.87 | < 0.001 |
No previous colonoscopy | 1.83 | 1.39-2.52 | < 0.001 | |||
Aspirin use | 0.96 | 0.58-1.60 | 0.89 | |||
Diabetes | 0.81 | 0.52-1.26 | 0.36 | |||
Symptoms of CRC | 0.90 | 0.68-1.19 | 0.65 |
- Citation: Rattan N, Willmann L, Aston D, George S, Bassan M, Abi-Hanna D, Anandabaskaran S, Ermerak G, Ng W, Koo JH. To scope or not - the challenges of managing patients with positive fecal occult blood test after recent colonoscopy. World J Gastrointest Oncol 2022; 14(9): 1798-1807
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1798.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1798